Anti-infectives and gynecology divisions on the block: Zydus Cadila to lower debt from the sale!


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Zydus Cadila puts two of it's division on block

Zydus Cadila, which is a group company of listed drug-maker Cadila Healthcare is set to trim by strategy, selling off its two units--anti-infectives and gynaecology—in approximately Rs1000 to Rs1200 to reduce its debt and strengthen its ledger.
Earlier this year, Zydus Cadila borrowed money to help finance its Rs 4,600-crore acquisition Heinz India’s consumer wellness business and now selling off the two said units are part of a structural strategy to buoyant the balance sheet of the company.
Reportedly, Zydus has approached its rivals like Sun Pharmaceutical Industries and Cipla alongside the pharma biz investors like Blackstone, KKR, Advent International and Carlyle, however, they remained unavailable for comment.
Jefferies, an investment bank has been authorised to run a formal process to find a buyer.
The Ahmedabad-based company shows that the anti-infectives and gynaecology divisions contributed Rs 565 crore and Rs 282 crore to FY19 overall annual revenue of Rs 11,940 crore.
The anti-infective division that was acquired from Biochem Pharma in 2011, named Vivo sells under brands such as Ampilox, Biotax, Amicin, Monotax. Zydus’s gynaecology division, Gynova, sells drugs like Provironum, ZYHCG, Ovucet, and Ccliya that treat infertility.

Tags : #zyduscadila #sale #twodivisions #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026